References
- Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology 1988; 38: 409–413.
- Brooks BR, Sanjak M, Belden DS, Waclawik AJ. Motor neurone disease: Basic designs, sample sizes and pitfalls. In: RJ Guiloff, ed. Clinical Trials in Neurology. London: Springer Verlag, 2001: 427–448.
- Andres PL, Skerry LM, Thornell B, Portney LG, Finison LJ, Munsat TL. A comparison of three measures of disease pro- gression in ALS. J Neurol Sci 1996; 139: 64–70.
- Sanjak M, Belden DS, Cook T, Brooks BR. Muscle strength measurement. In: RD Lane, ed. Handbook of Muscle Disease. New York: Marcel Dekker, 1996: 19–31.
- National Isometric Muscle Strength (NIMS) Database Con- sortium. Muscular weakness in assessment: Use of normal isometric database. Arch Phys Med 1996; 17: 1251–1255.
- Hoagland RJ, Mendoza M, Armon C et al and the Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Muscle Nerve 1997; 20: 691–695.
- Escolar DM, Henricson EK, Mayhew J et al. Clinical evalua- tor reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001; 24: 787–793.
- ALS CNTF Treatment Study (ACTS) Phase I–II Study Group (1996). The Amyotrophic Lateral Sclerosis Functional Rating Scale – Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996; 53(2): 141–147.